Novavax, Inc. (NVAX) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.83 --0%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
NEOV, MANU, CTAS, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $4.64 million versus the consensus estimate of $7.36 million.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Union Pacific (UNP) Reiterated at Market Outperform by Citizens - Most Attractive in Rail Group
- JPMorgan Upgrades Graphic Packaging Holding Company (GPK) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
